Biotechnology

Click here to view our Biotechnology professionals

Our biotechnology practice includes such services as patent procurement, interference and opposition practice, litigation - both plaintiff and defense positions, licensing, technology transfer, patent validity and infringement opinions, and other areas of client counseling. Spearheaded by attorneys, agents, and law clerks with advanced degrees in such areas as biochemistry, molecular biology, immunology, and plant sciences, our biotechnology practice has the combination of technical expertise and legal experience that enables us to represent our clients in the most sophisticated arenas.

We work extensively in cutting-edge sub-specialties, such as the production and use of antisense oligonucleotides, ribozymes, recombinant genes and proteins, monoclonal antibodies, gene-gun applications, and pharmaceutical products for disease treatment and diagnosis, apparatuses and techniques for isolating, labeling, and detecting molecules of biological importance. Our focus on the burgeoning field of nanotechnology is one of the most comprehensive in the legal profession. We understand the far-reaching implications of nanotechnology and its potential to transform technology as we now know it.

Our substantial experience extends worldwide and includes strategic development and the protection of intellectual property for Fortune 500 multinational corporations as well as start-up biotechnology companies.

P: 312.935.2369
F: 312.913.0002
P: 312.913.2140
F: 312.913.0002
Senior Patent Agent
P: 312.913.3357
F: 312.913.0002
P: 312.913.2130
F: 312.913.0002
Senior Patent Agent
P: 312.913.2146
F: 312.913.0002
P: 312.913.3330
F: 312.913.0002
P: 312.913.3345
F: 312.913.0002
P: 312.913.3317
F: 312.913.0002
P: 312.913.3352
F: 312.913.0002
P: 312.913.2109
F: 312.913.0002
P: 312.913.2121
F: 312.913.0002
P: 312.913.3332
F: 312.913.0002
P: 312.913.2117
F: 312.913.0002
P: 312.913.3369
F: 312.913.0002
P: 312.913.3315
F: 312.913.0002
P: 312.913.3333
F: 312.913.0002
P: 312.913.2135
F: 312.913.0002
P: 312.913.3366
F: 312.913.0002
P: 312.913.2116
F: 312.913.0002
P: 312.913.2106
F: 312.913.0002
P: 312.935.2371
F: 312.913.0002
P: 312.935.2372
F: 312.913.0002
P: 312.913.3311
F: 312.913.0002
Senior Patent Agent
P: 312.913.3393
F: 312.913.0002
Master Patent Agent
P: 312.913.3346
F: 312.913.0002
P: 312.913.2101
F: 312.913.0002
P: 312.913.3344
F: 312.913.0002
P: 312.913.2126
F: 312.913.0002
P: 312.913.2145
F: 312.913.0002
P: 312.913.3335
F: 312.913.0002
P: 312.913.3349
F: 312.913.0002
P: 312.913.2133
F: 312.913.0002
P: 312.913.2136
F: 312.913.0002
P: 312.935.2379
F: 312.913.0002
P: 312.913.3368
F: 312.913.0002
P: 312.913.3301
F: 312.913.0002
P: 312.913.2114
F: 312.913.0002
P: 312.913.2132
F: 312.913.0002

Upcoming Events

May 25, 2016
MBHB Partner Dr. Kevin Noonan Is the Featured Presenter at this ALA-Sponsored Session
May 25, 2016
MBHB Partner Dr. Kevin Noonan Is a Featured Presenter at this IPO-Sponsored Webinar
June 11, 2016
MBHB Partner Kirsten Thomson Is a Featured Presenter for this Program
June 15, 2016

Past Event

May 18, 2016
May 10-12, 2016
MBHB Partners Dr. Kevin Noonan and Dr. Donald Zuhn are Featured Presenters at this PLI-Sponsored Seminar
April 26, 2016
MBHB Partner Patrick Gattari is the Featured Presenter at this MATTER-Sponsored Program
April 12, 2016
April 12, 2016
MBHB Partner Dr. Emily Miao is the Featured Presenter at this MATTER-Sponsored Program

Publications

May 11, 2016
MBHB snippets Alert - May 11, 2016

This afternoon, President Obama signed the Defend Trade Secrets Act of 2016 (“DTSA”) into law, creating a new Federal cause of action for misappropriation of trade secrets. The new law is the most significant expansion of Federal intellectual property law in a generation, and brings with it significant benefits – but also new responsibilities – for intellectual property owners and employers. And in this era of narrowed subject matter eligibility for patenting, the DTSA may provide enough of an incentive for intellectual property owners to keep more information as trade secrets.
Winter 2016 (snippets)
February 4, 2016, marked the one-year anniversary of the initial In re Cuozzo Speed Technologies, LLC Federal Circuit decision – the first opinion stemming from the first appeal of the first final written decision of the first inter partes review (“IPR”) ever filed. From the time that decision came out until the end of January 2016, there have been at least 56 appeals from IPRs and Covered Business Method (“CBM”) patent reviews resolved by this appeals court.
Winter 2016 (snippets)
The Defend Trade Secrets Act of 2015, a bill to establish a federal cause of action for trade secret misappropriation, has continued its progress through Congress with a favorable hearing before the Senate Judiciary Committee on December 2, 2015, that led to unanimous committee approval of an amended version on January 28, 2016. Despite the legislative logjam created by the impending election, and the failure to pass a similar bill during the last term of Congress, there is a significant probability that the bill will pass into law.
Winter 2016 (snippets)
It has been over 20 months since the Supreme Court handed down the landmark decision in Alice Corp. v. CLS Bank Int’l, effectively limiting the scope of patent-eligible subject matter. In particular, software and business method patents and applications now receive a higher level of scrutiny under Alice than had previously been the case.
Winter 2016 (snippets)
The USPTO offers a spectrum of programs that can be used to expedite examination of patent applications, which include Prioritized Examination (PE), Accelerated Examination (AE), the Patent Prosecution Highway (PPH), Petitions to Make Special (PTMS), Full First Action Interviews (FFAI), the After Final Consideration Pilot (AFCP 2.0) program, and the Collaborative Search Pilot (CSP) program.
Fall 2015 (snippets)
This is the perfect time and environment in which to take a close look at your trademark portfolio. It is the time to be thankful for your brand’s position in the market and the investments you have made into searching, registering, maintaining, and enforcing your trademarks. But it is also the time to set goals and develop plans to make better use of your trademark portfolios.
Close
Generate a PDF of your page(s)
Clear
Close
Remove
Page has been queued
An error has occurred
Add
Added to queue
View
Confirm Delete All Message
No Items in Packet Message
To add a page, select Add. To view the package, select View.
false
http://www.mbhb.com/services/xpqServiceDetail.aspx?xpST=ServiceDetail&service=296&pdf=yes
a[href='javascript:packetBuilderSingleClick(document.title);']